We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Nuvalent Inc is a biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer, designed to overcome the limitations of existing therapies for clinically proven kinase targets. Nuvalent Inc is a biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer, designed to overcome the limitations of existing therapies for clinically proven kinase targets.
Ask ADVFN Intelligence (AI)
Nuvalent Announces Closing of Upsized Public Offering of Common Stock PR Newswire CAMBRIDGE, Mass., Sept. 18, 2024 CAMBRIDGE, Mass., Sept. 18, 2024 /PRNewswire/ -- Nuvalent, Inc. (Nasdaq: NUVL...
| Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.95 | -0.91902873174 | 103.37 | 106.32 | 99.35 | 313127 | 102.46468068 | CS |
| 4 | -2.56 | -2.43855972566 | 104.98 | 110 | 98.6 | 641496 | 103.50517529 | CS |
| 12 | 21.31 | 26.2729626433 | 81.11 | 113.51 | 64.67 | 463521 | 94.23930853 | CS |
| 26 | 36.64 | 55.7008209182 | 65.78 | 113.51 | 61.795 | 439130 | 83.07097598 | CS |
| 52 | 45.22 | 79.0559440559 | 57.2 | 113.51 | 49.02 | 479470 | 75.80438133 | CS |
| 156 | 81.75 | 395.500725689 | 20.67 | 113.51 | 7.09 | 330175 | 53.50632739 | CS |
| 260 | 84.32 | 465.856353591 | 18.1 | 113.51 | 7.09 | 323531 | 52.32693437 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
